This is not a critique on the original poster. He is just the messenger.
Ok, digging into the study, even taking into account the weaknesses described by other posters, it did show a difference in alleviating symptoms in the hcq group which did not receive other antivirals.
Also showed reductions in inflammatory markers (crp).
Also- given that only 1% of the study participants had what was considered a serious case of the illness, neither group had any deaths(at least I couldn’t find a report of any in the outcomes), so we can’t compare mortality rates.
I could design and perform better studies as an undergrad- and could certainly draw more accurate conclusions. Pretty weak tea.
1% of the study participants